𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Optimal duration of treatment for acute hepatitis c in human immunodeficiency virus–positive individuals?

✍ Scribed by Gail V. Matthews; Gregory J. Dore

Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
632 KB
Volume
53
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

✦ Synopsis

Shorter duration and lower dose of peginterferon alfa-2a therapy results in inferior HBeAg seroconversion rates compared with the duration and dose of 48 weeks and 180 lg: NEPTUNE study.

📜 SIMILAR VOLUMES

Treatment of acute hepatitis C in human
Treatment of acute hepatitis C in human immunodeficiency virus–infected patients: The HEPAIG study
✍ Lionel Piroth; Christine Larsen; Christine Binquet; Laurent Alric; Isabelle Aupe 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB 👁 2 views

and Stanislas Pol 12 for the Steering Committee of the HEPAIG Study Acute hepatitis C continues to be a concern in men who have sex with men (MSM), and its optimal management has yet to be established. In this study, the clinical, biological, and therapeutic data of 53 human immunodeficiency virus

Effect of the interleukin-6 C174G gene p
Effect of the interleukin-6 C174G gene polymorphism on treatment of acute and chronic hepatitis C in human immunodeficiency virus coinfected patients
✍ Jacob Nattermann; Martin Vogel; Thomas Berg; Mark Danta; Baumgarten Axel; Christ 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 340 KB 👁 1 views

Hepatitis C virus (HCV)/human immunodeficirency virus (HIV) coinfection poses a difficult therapeutic problem. Response to HCV-specific therapy is variable but might be influenced by host genetic factors, including polymorphisms of cytokine genes. Here, we studied whether interleukin-6 (IL-6) C174G

Evaluation of a total hepatitis C virus
Evaluation of a total hepatitis C virus (HCV) core antigen assay for the detection of antigenaemia in anti-HCV positive individuals
✍ Pierpaolo Valcavi; Maria Cristina Medici; Francesca Casula; Maria Cristina Arcan 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 211 KB

## Abstract A new, sensitive enzyme immunoassay has been developed for detecting and quantifying total hepatitis C virus (HCV) core antigen in anti‐HCV positive or negative sera (“__trak__‐__C__™”, Ortho Clinical Diagnostics, Raritan, NJ). The purpose of this study was to evaluate the performance o